Span Divergent Ltd

NSE: SPANDIAQ · BSE: 524727 · Pharmaceuticals & Biotechnology · 16 announcements

Share price: ₹21.60
Market cap: ₹15.69 Cr
Revenue (annual): ₹17.22 Cr
Net profit (annual): ₹-2.50 Cr
P/E (TTM): -5.0×Sector 47.4×
Promoter holding: 48.13%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 3 Financial Results 3 Debt & Borrowing 2 Capital Structure Change 2 Board Meeting Date 2 Annual General Meeting 2 Legal & Regulatory 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

17 Apr 2026 22:07 IST BSE

Debt & Borrowing

Span Divergent Debt & Borrowing

Span Divergent Ltd (BSE: 524727) submitted its annual disclosure confirming it does not meet the Large Corporate criteria for FY 2025-26. The company reported zero incremental borrowings and no mandatory debt issuance requirements for the 2025-2027 block period. No penalties were applicable for the previous block.

Execution: FY 2025-26, FY 2026-27

Read the filing ↗

17 Apr 2026 22:01 IST BSE

Debt & Borrowing

Span Divergent Debt & Borrowing: ₹1.92 Cr

Span Divergent Limited submitted its initial disclosure under the SEBI Large Corporate framework for FY 2026. The company reported outstanding borrowings of ₹1.92 Crore as of March 31, 2026. It confirmed that it does not meet the criteria to be classified as a Large Corporate under the specified SEBI circular.

Value: ₹1.92 Cr

Read the filing ↗